The Clinical Pharmacology and Quantitative Medicine (CPQM) group at GSK is a newly established organization dedicated to becoming a Centre of Excellence in Model-Informed Drug Development (MIDD). CPQM uniquely integrates expertise in clinical pharmacology, digital medicine, translational imaging, and mechanistic and systems modeling.
Under the strategic leadership of the MIDD Head, the MIDD team drives strategy and innovation in clinical pharmacology and quantitative medicine. This function is essential for advancing GSK's MIDD capabilities, efficiency, and impact, with a strong focus on respiratory, immunology, inflammation, hepatology,
neurodegeneration, and emerging areas within the Respiratory, Immunology &
Inflammation Research Unit (RIIRU). The MIDD team is responsible for leading the development and execution of comprehensive therapeutic or sub-therapeutic area MIDD evidence strategies across RIIRU.
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.